NCT02027090 - High Dose Versus Routine Dose Icotinib in Advanced Non-small Cell Lung Cancer Patients With Stable Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

June 30, 2016

Study Completion Date

December 31, 2016

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG

Routine dose icotinib

Icotinib is administered 125 mg three times daily.

DRUG

Higher dose icotinib

After 8-week induction of icotinib with a dose of 125 mg three times daily, icotinib is administered 375 mg three times per day.

Trial Locations (1)

Shanghai Chest Hospital Affiliated to Shanghai Jiaotong University, Shanghai